Lupin shuts drug plant in Gujarat after 17 staff test positive for COVID-19

Lupin makes everything from heart drugs to asthma and diabetes medicines that are sold in over 100 countries, with its largest market being North America.

Reuters

July 14, 2020 / 10:18 PM IST

Representative image

live

bselive
nselive

Volume

Todays L/H

Indian drugmaker Lupin Ltd has shut one of its manufacturing plants in Gujarat after at least 17 employees at the site tested positive for COVID-19, two government officials said on Tuesday.

Lupin, one of India's top five drugmakers, did not immediately respond to requests for comment. The company has some 11 manufacturing plants at the Ankleshwar site in Gujarat state, which is spread out over 40 acres and has 984 employees, according to the company website.

Employees from one of those plants, which produces tuberculosis drugs, have tested positive in recent days, said MD Modia, a senior district official. "The plant was shut on July 12 after the cases were confirmed," said Modia, adding that the site has since been sanitized. "No cases have been reported from the other plants in the facility and their operations are unaffected," he said.

Other employees who have come in contact with those who have tested positive are also in the process of being tested, said another senior government official from the Bharuch district.

Lupin makes everything from heart drugs to asthma and diabetes medicines that are sold in over 100 countries, with its largest market being North America.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show